Cargando…

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications

Objectives: The objective of this study was to determine the identification rate of substandard and falsified medications and its association with knowledge among public. Methods: This descriptive cross-sectional study was conducted in different geographic areas among a convenient sample of people a...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Dahiyat, Faris, Fahelelbom, Khairi M. S., Jairoun, Ammar Abdulrahman, Al-Hemyari, Sabaa Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575769/
https://www.ncbi.nlm.nih.gov/pubmed/34765583
http://dx.doi.org/10.3389/fpubh.2021.754279
_version_ 1784595740442492928
author El-Dahiyat, Faris
Fahelelbom, Khairi M. S.
Jairoun, Ammar Abdulrahman
Al-Hemyari, Sabaa Saleh
author_facet El-Dahiyat, Faris
Fahelelbom, Khairi M. S.
Jairoun, Ammar Abdulrahman
Al-Hemyari, Sabaa Saleh
author_sort El-Dahiyat, Faris
collection PubMed
description Objectives: The objective of this study was to determine the identification rate of substandard and falsified medications and its association with knowledge among public. Methods: This descriptive cross-sectional study was conducted in different geographic areas among a convenient sample of people aged 18 or older. A validated web-based electronic questionnaire was used for data collection tool. The questionnaire contained three sections assessing the following: (1) Sociodemographic data; (2) Knowledge regarding counterfeit medicines; and (3) Ability to identify counterfeit medicines, according to 12 questions rated on a five-point Likert scale. Univariate and multivariate logistic regression analyses were used to assess the association between sociodemographic factors and counterfeit medication identification rate. Results: A total of 320 people participated in the study. Only 98 participants (30.6%, 95% CI 25.6–35.7%) identified the counterfeit medications. Ability to correctly identify counterfeit medications was significantly higher in participants who were older (p = 0.016), single (p = 0.001), Asian (p = 0.001), or American (p = 0.019), as well as those who indicated that they would check the certification of the medications (p = 0.015) and report counterfeit medications to the authorities (p < 0.0001). Conclusions: These results underscore the need for greater public awareness of the hazards associated with counterfeit medicines.
format Online
Article
Text
id pubmed-8575769
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85757692021-11-10 Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications El-Dahiyat, Faris Fahelelbom, Khairi M. S. Jairoun, Ammar Abdulrahman Al-Hemyari, Sabaa Saleh Front Public Health Public Health Objectives: The objective of this study was to determine the identification rate of substandard and falsified medications and its association with knowledge among public. Methods: This descriptive cross-sectional study was conducted in different geographic areas among a convenient sample of people aged 18 or older. A validated web-based electronic questionnaire was used for data collection tool. The questionnaire contained three sections assessing the following: (1) Sociodemographic data; (2) Knowledge regarding counterfeit medicines; and (3) Ability to identify counterfeit medicines, according to 12 questions rated on a five-point Likert scale. Univariate and multivariate logistic regression analyses were used to assess the association between sociodemographic factors and counterfeit medication identification rate. Results: A total of 320 people participated in the study. Only 98 participants (30.6%, 95% CI 25.6–35.7%) identified the counterfeit medications. Ability to correctly identify counterfeit medications was significantly higher in participants who were older (p = 0.016), single (p = 0.001), Asian (p = 0.001), or American (p = 0.019), as well as those who indicated that they would check the certification of the medications (p = 0.015) and report counterfeit medications to the authorities (p < 0.0001). Conclusions: These results underscore the need for greater public awareness of the hazards associated with counterfeit medicines. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8575769/ /pubmed/34765583 http://dx.doi.org/10.3389/fpubh.2021.754279 Text en Copyright © 2021 El-Dahiyat, Fahelelbom, Jairoun and Al-Hemyari. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
El-Dahiyat, Faris
Fahelelbom, Khairi M. S.
Jairoun, Ammar Abdulrahman
Al-Hemyari, Sabaa Saleh
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
title Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
title_full Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
title_fullStr Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
title_full_unstemmed Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
title_short Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
title_sort combatting substandard and falsified medicines: public awareness and identification of counterfeit medications
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575769/
https://www.ncbi.nlm.nih.gov/pubmed/34765583
http://dx.doi.org/10.3389/fpubh.2021.754279
work_keys_str_mv AT eldahiyatfaris combattingsubstandardandfalsifiedmedicinespublicawarenessandidentificationofcounterfeitmedications
AT fahelelbomkhairims combattingsubstandardandfalsifiedmedicinespublicawarenessandidentificationofcounterfeitmedications
AT jairounammarabdulrahman combattingsubstandardandfalsifiedmedicinespublicawarenessandidentificationofcounterfeitmedications
AT alhemyarisabaasaleh combattingsubstandardandfalsifiedmedicinespublicawarenessandidentificationofcounterfeitmedications